DIABNEXT announces the appointment of Didier MOIRE as Vice President of Sales and Development.
Hypoglycemia is a drop in the level of glucose in the blood, which can cause neurological disorders such as paralysis, double vision or loss of consciousness (blood sugar less than 0.70 g/l). What are the signs of hypoglycemia? Generally, the signs of
DIABNEXT WILL BE IN BERLIN FOR THE ATTD19 CONFERENCE, COME AND SEE OUR DIGITAL DIABETES INNOVATIONS, BOOTH #43
The 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) will take place in Berlin between 20-23 of February. It will bring together a multitude of key players from the diabetes world as well as family providers, scientists, start-ups and many
DIABNEXT is moving its headquarters to 10 rue Treilhard, in the 8th arrondissement of Paris, France in the Morning Monceau space. This implementation makes it possible to maintain close relations with key hospitals for Diabetes in Europe, and in particular
DIABNEXT ATTENDED THE 11th INTERNATIONAL CONFERENCE ON ADVANCED TECHNOLOGIES & TREATMENTS FOR DIABETES (ATTD 2018)
Advanced Technologies & Treatments for Diabetes (ATTD) is a unique and innovative conference. The ATTD attracts more than 2,500 participants each year, including leading researchers, clinical practitioners, and industry professionals and companies from around the world to exchange ideas and information on diabetes
AADE is a multi-disciplinary professional membership organisation dedicated to improving diabetes care through innovative education, management and support. With more than 14,000 professional members including nurses, dieticians, pharmacists, exercise specialists, and others, AADE has a vast network of practitioners working